Boulding Mark Elliott

Exec. VP And CLO | Exec. VP And CLO

1 company

Good

Trades Analyzed

12M Win Rate

30.0%

Avg 3M Return

-0.1%

Avg 12M Return

-12.5%

Boulding Mark Elliott is an Exec. VP And CLO at PTC Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 55 sells.

Estimated insider holdings value: $7.3M based on current market prices.

Holdings by Company

PTCTJul 6, 2026

Current Shares106.0K

Value$7.34M

Net Activity-650,908

Bought: 0Sold: 650.9K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 6, 2026	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	5,079	$85.08	$432,117.53	-0.6%	-	-
Jun 17, 2026	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	10,462	$78.65	$822,867.75	-2.4%	-	-
Apr 6, 2026	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	2,265	$69.45	$157,293.27	-1.1%	+20.9%	-
Jan 9, 2026	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sell	6,347	$77.06	$489,080.53	-0.9%	-8.6%	-
Jan 7, 2026	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	6,618	$77.31	$511,641.42	-0.7%	-9.9%	-
Jan 5, 2026	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	2,266	$75.55	$171,191.98	-0.6%	-10.2%	-
Nov 17, 2025	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	2,812	$75.99	$213,686.89	-0.9%	-8.5%	-
Oct 7, 2025	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	3,375	$63.43	$214,091.17	-1.1%	+20.1%	-
Oct 6, 2025	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	24,921	$65.75	$1,638,548.63	-2.1%	+18.5%	-
Sep 12, 2025	PTCT Ptc Therapeutics, Inc.	Exec. VP And CLO	Sale+OE	47,724	$61.17	$2,919,284.44	-6.2%	+23.5%	-